Digestive diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age = 18 years and age = 80 years, no gender restrictions. (2) Proposed minimally invasive gastric (gastric cancer, gastric mesenchymal tumor, etc.), colorectal (colon cancer, rectal cancer, etc.), and appendiceal (benign or malignant appendiceal disease) surgeries, among others: ? Patients with gastric cancer must meet primary gastric cancer stage I/II/III; ? Patients with gastric mesenchymal tumors must have no distant metastases; ? Patients with colorectal cancer must meet primary colorectal cancer stage I/II/III; ? Patients with appendiceal malignancies must have no distant metastases; (3) Patients fully understand the benefits and risks of the trial, are willing to participate in the trial, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Unable to tolerate surgery or anesthesia because of severe heart, lung, brain, liver, or kidney disease; (2) Unable to tolerate pneumoperitoneum; (3) Severe coagulation disorders; (4) Patients with active tuberculosis; (5) Patients with severe uncontrolled medical conditions or acute infectious diseases; (6) Inability to perform puncture to establish pneumoperitoneum due to risk of extensive and severe adhesions in the abdominal cavity, etc., as judged by the investigators; (7) Physical exhaustion, excessive ascites, internal bleeding, or shock; (8) Gastric cancer lymph node metastases fused and engulfed major blood vessels; (9) Colorectal cancer obstruction with marked abdominal distension; (10) Extensive tumor metastasis in the abdomen and pelvis; (11) Emergency surgery for acute tumor obstruction, perforation, bleeding, etc.; (12) Tumor perforation combined with acute peritonitis; (13) Pregnant and lactating women; (14) History of epilepsy, psychosis, or cognitive impairment; (15) Other conditions that the investigator deems unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operation efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications incidence;Adverse event rate; | — |
Countries
China
Contacts
The First Affiliated Hospital of Wenzhou Medical University